Status:
RECRUITING
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Lead Sponsor:
Thomas Advanced Medical LLC
Collaborating Sponsors:
HeartStem Institute
NuStem
Conditions:
Autoimmune Diseases
Cardiovascular Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial finding...
Detailed Description
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial finding...
Eligibility Criteria
Inclusion
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
Exclusion
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
Key Trial Info
Start Date :
July 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 9 2030
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04684602
Start Date
July 9 2020
End Date
December 9 2030
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, California, United States, 92032